Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Breathe (Sheffield, England)|May 14, 2025
Lung transplantation for interstitial lung diseaseNicola J Ronan, Feargal Helly, Michelle A MurrayPresse Medicale (Paris, France : 1983)|May 31, 2017
Current and emerging comorbidities in cystic fibrosisNicola J Ronan, Joseph Stuart Elborn, Barry J PlantClinics in Chest Medicine|February 11, 2023
Conventional and Novel Approaches to Immunosuppression in Lung TransplantationCaroline M Patterson, Elaine C Jolly, Fay Burrows, et al.Chest|September 2, 2015
The Role of Ivacaftor in Severe Cystic Fibrosis in a Patient With the R117H MutationNicola J Ronan, Claire Fleming, Grace O'Callaghan, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 7, 2021
Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftorGisli G Einarsson, Nicola J Ronan, Denver Mooney, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 1, 2018
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV<sub>1</sub>) in cystic fibrosis patients receiving ivacaftor treatmentBéla Nagy, Zsolt Bene, Zsolt Fejes, et al.The Journal of Infection|January 14, 2021
A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and levelJennifer Deane, Fiona Fouhy, Nicola J Ronan, et al.Chest|October 18, 2017
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With IvacaftorNicola J Ronan, Gisli G Einarsson, Maria Twomey, et al.Pageof 1